Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (24447)	8/13/1998 1:37:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< Just my point, they made a huge mistake, they should have taken the payment from Lilly. >> Ahhhhhhh! So, you don't base your opinion solely on the price of SRGN shares. Mudrat, would you mind explaining why you think that the payment would've been a better value? You did say that it was a huge mistake. Ligand negotiated with Seragen for about 16 months, in attempt to buy them. At least, you could've called Ligand and informed them about why they were making a huge mistake. Thanks, Bob